BUZZ-Philips seen down after flagging delayed orders, pressure on D&T segment
PHG•Shares seen lower after Q2 order warning
Shares in Philips PHG.AS are seen down 3-5% after the company flagged delayed orders and market pressure on its Diagnosis & Treatment (D&T) segment in Q2.
The Dutch healthcare technology company reports a 1% decline in order intake due to large orders shifting into Q3. It also flagged market pressure in China weighing on D&T.
Traders say that while the company raised its outlook on tariff refunds, the focus would be on the decline in order growth and the soft margin performance in D&T.
RBC analysts also expect scrutiny on the order intake decline, "particularly given recent investor concerns around the US hospital capex environment".
"While the reiteration of underlying FY guidance is encouraging, the H2 margin ramp implied by guidance looks to be more challenging," they add.
On Monday, U.S.-listed shares lost 4.4% to $25.02.
